Target intelligence / Profile preview

High mobility group nucleosome binding domain 1 pseudogene 32 (HMGN1P32)

Target
HMGN1P32
Molecular classification
Other (Pseudogene)
01

Overview

High mobility group nucleosome binding domain 1 pseudogene 32 (HMGN1P32) is a *pseudogene*—a noncoding genomic DNA sequence similar to HMGN1, which encodes a nucleosome-binding protein involved in chromatin structure and transcriptional regulation[3][5][7]. HMGN1P32 does **not** encode a functional protein and is not considered a receptor, enzyme, or traditional therapeutic target. While some pseudogenes can generate regulatory RNAs involved in post-transcriptional regulation of their parent genes or serve as microRNA decoys, no published functional data exist specifically for HMGN1P32[1][2]. Thus, it is primarily classified as a genomic pseudogene, with no direct disease link or drug interactions described. Key Notes: - HMGN1P32 is not a valid therapeutic target, nor a functional receptor/protein[3][5][7]. - Entry may be "incorrect" as a target for drug discovery purposes, but the name itself is correctly identified as a human pseudogene[3][5]. - No evidence links HMGN1P32 to actionable drug mechanisms, biomarker use, or clinical safety concerns. - The only significant functional potential is speculative, based on analogies to other pseudogenes possibly involved in gene regulation[1][2].

Other names
HMGN1P32
02

Biological functions

Potential regulatory RNA function (by analogy to other pseudogenes)no direct protein function
03

Disease associations

Other (Possible indirect involvement in gene regulation; no direct disease association known for HMGN1P32)

Beyond the preview

Go deeper on High mobility group nucleosome binding domain 1 pseudogene 32 (HMGN1P32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 32 (HMGN1P32).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call